Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Primary Myelofibrosis 28Myeloproliferative Disorders 21Polycythemia Vera 16Thrombocythemia, Essential 7Neoplasms 7Pancreatic Neoplasms 6Multiple Myeloma 6Leukemia 6Hematologic Diseases 5Myelodysplastic Syndromes 4Graft vs Host Disease 4Colorectal Neoplasms 4Bone Marrow Diseases 4Thrombocytosis 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Carcinoma, Non-Small-Cell Lung 3Bronchiolitis Obliterans Syndrome 3Breast Neoplasms 3Prostatic Neoplasms 2Lymphoma 2Uveal Melanoma 1Thalassemia 1Recurrence 1Preleukemia 1Precancerous Conditions 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms by Histologic Type 1

Interventions

Fulvestrant 9Alpelisib 6Letrozole 4serabelisib 3ribociclib 3palbociclib 3duvelisib 3berzosertib 3Paclitaxel 3PX-866 3Cetuximab 3sapanisertib 2pembrolizumab 2parsaclisib 2binimetinib 2Topotecan 2NVP-BKM120 2Irinotecan 2Gemcitabine 2venetoclax 1tipifarnib 1talazoparib 1sotorasib 1ruxolitinib 1olaparib 1obinutuzumab 1niraparib 1lorlatinib 1liposomal doxorubicin 1gedatolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Hereditary Sensory and Autonomic Neuropathies × ruxolitinib × Clear all
NCT02718300 2024-05-01

A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

Incyte Corporation

Phase 2 Terminated
74 enrolled 40 charts
Myeloid

Myeloproliferative Disorders, Hereditary Sensory and Autonomic Neuropathies, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡